ABOUT THE EVENT
Date: Monday, May 4, 2026 8am–5:45pm EDT
Event Location: Boston, Massachusetts
The CNS Discovery Xchange Boston 2026 is a high-impact, one-day gathering designed for leaders in pharma and biotech who are driving the next wave of CNS innovation. Taking place on 5 May 2026 in Boston, this exclusive forum brings together a curated community of senior scientists, program heads, and decision-makers who are actively shaping the future of CNS therapeutics. Instead of a traditional conference format, the Xchange model creates an immersive environment built around expert-led discussions, targeted collaboration, and meaningful networking that accelerates real scientific and strategic progress.
This year’s program spans five essential tracks—Biomarkers in Discovery, Target Discovery, Disease Models, Novel Modalities, and Blood–Brain Barrier/Drug Delivery—allowing participants to dive into the most urgent challenges and most promising breakthroughs in CNS R&D. From improving translational reliability and identifying new therapeutic targets to harnessing emerging modalities and developing smarter ways to cross the BBB, each track offers insight-rich sessions designed to spark new ideas and drive actionable solutions.
Across the day, attendees will engage in keynote presentations, sponsor-led roundtables, interactive poster sessions, and pre-scheduled one-to-one meetings that foster focused knowledge exchange and open the door to new partnerships. With a networking lunch and an end-of-day reception, the event provides numerous opportunities to connect with peers who are facing similar challenges, exploring similar scientific questions, and pushing toward similar goals. For organizations aiming to strengthen their CNS pipeline, discover new collaborators, or stay ahead of the scientific curve, the CNS Discovery Xchange Boston 2026 offers a rare combination of depth, access, and relevance—making it an event worth securing a spot for early.